Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M262Revenue (TTM) $M114Net Margin (%)-66.5Altman Z-Score-2.7
Enterprise Value $M88.1EPS (TTM) $-1.6Operating Margin %-66.0Piotroski F-Score2
P/E(ttm)--Beneish M-Score-4.2Pre-tax Margin (%)-66.2Higher ROA y-yY
Price/Book4.210-y EBITDA Growth Rate %--Quick Ratio3.1Cash flow > EarningsY
Price/Sales2.35-y EBITDA Growth Rate %-13.0Current Ratio3.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-27.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-76.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M49.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INFIGeorge Soros 2013-06-30 Sold Out -0.02%$16.192 - $50.09
($30.95)
$ 5.19-83%Sold Out0
INFIGeorge Soros 2013-03-31 Reduce-0.01%$32.93 - $49.37
($39.51)
$ 5.19-87%Reduce -46.67%40,000
INFIGeorge Soros 2012-12-31 Buy 0.03%$17.74 - $35.04
($25.26)
$ 5.19-79%New holding75,000
INFIFirst Eagle Investment 2012-06-30 Sold Out -0.0086%$11.84 - $13.88
($12.85)
$ 5.19-60%Sold Out0
INFIFirst Eagle Investment 2012-03-31 Reduce-0.01%$5.9781 - $12.16
($7.96)
$ 5.19-35%Reduce -54.94%180,000
INFIFirst Eagle Investment 2011-09-30 Reduce-0.01%$6.17 - $10.36
($7.87)
$ 5.19-34%Reduce -25.85%464,241
INFIWilbur Ross 2011-06-30 Sold Out $5.61 - $8.19
($6.53)
$ 5.19-21%Sold Out0
INFIWilbur Ross 2010-12-31 Reduce-0.02%$5.12 - $6.86
($6.13)
$ 5.19-15%Reduce -63.91%7,415
INFIFirst Eagle Investment 2010-12-31 Add0.01%$5.12 - $6.86
($6.13)
$ 5.19-15%Add 60.34%585,437
INFIWilbur Ross 2010-09-30 Reduce-0.01%$4.62 - $6.3
($5.51)
$ 5.19-6%Reduce -25.39%20,545
INFIFirst Eagle Investment 2010-09-30 Add$4.62 - $6.3
($5.51)
$ 5.19-6%Add 29.72%365,123
INFIFirst Eagle Investment 2010-06-30 Add0.01%$5.88 - $7.94
($6.59)
$ 5.19-21%Add 566.95%281,460
INFIFirst Eagle Investment 2009-12-31 Add$5.5 - $6.57
($5.92)
$ 5.19-12%Add 451.43%42,201
INFIFirst Eagle Investment 2009-09-30 Buy $5.42 - $8.8
($6.97)
$ 5.19-26%New holding7,653
INFIWilbur Ross 2009-03-31 Buy 0.12%$7.1 - $8.28
($7.9)
$ 5.19-34%New holding28,437
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INFI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Perkins Adelene QPresident & CEO 2015-06-25Sell5,000$10.93-52.52view
Palombella Vito J.Chief Scientific Officer 2015-06-15Sell4,737$10.97-52.69view
Perkins Adelene QPresident & CEO 2015-05-27Sell10,000$12.81-59.48view
Perkins Adelene QPresident & CEO 2015-05-14Sell10,000$12.18-57.39view
Perkins Adelene QPresident & CEO 2015-03-16Sell20,000$16-67.56view
Perkins Adelene QPresident & CEO 2015-03-05Sell25,000$16.5-68.55view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-65view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-65view
Palombella Vito J.Chief Scientific Officer 2014-12-15Sell4,737$16.32-68.2view
Palombella Vito J.Chief Scientific Officer 2014-11-26Sell4,736$15-65.4view

Quarterly/Annual Reports about INFI:

News about INFI:

Articles On GuruFocus.com
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 
Infinity Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2009 

More From Other Websites
Infinis announces commercial operation of A'Chruach wind farm May 27 2016
Infinity Announces Presentations On Investigational Development Candidates, Duvelisib And IPI-549,... May 19 2016
Infinity Announces Presentations On Investigational Development Candidates, Duvelisib And IPI-549,... May 19 2016
ETF’s with exposure to Infinity Pharmaceuticals, Inc. : May 12, 2016 May 12 2016
Infinity Pharmaceuticals, Inc. :INFI-US: Earnings Analysis: Q1, 2016 By the Numbers May 11 2016
Disney Shutters Infinity Unit in Retreat From Video Games May 10 2016
INFINITY PHARMACEUTICALS, INC. Financials May 10 2016
Edited Transcript of INFI earnings conference call or presentation 4-May-16 8:30pm GMT May 05 2016
Infinity reports 1Q loss May 04 2016
Infinity reports 1Q loss May 04 2016
Infinity Provides Company Update And Reports First Quarter 2016 Financial Results May 04 2016
Infinity Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today May 04 2016
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... May 04 2016
Infinity Provides Company Update And Reports First Quarter 2016 Financial Results May 04 2016
INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 04 2016
Q1 2016 Infinity Pharmaceuticals Inc Earnings Release - After Market Close May 04 2016
Infinity to Participate in Three May Investor Conferences Apr 27 2016
Infinity to Participate in Three May Investor Conferences Apr 27 2016
Infinity Announces the Date of its First Quarter 2016 Financial Results Conference Call and Webcast Apr 20 2016
Infinity Announces the Date of its First Quarter 2016 Financial Results Conference Call and Webcast Apr 20 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)